Keyphrases
Metabolic Changes
100%
Hachimijiogan
100%
Mild Alzheimer's Disease
100%
Alzheimer's Disease Patient
100%
Acetylcholine
27%
Aspartic Acid
18%
Genome Analysis
18%
Plasma Metabolites
18%
Alzheimer's Disease
18%
Cognitive Dysfunction
18%
Partial Least Squares Discriminant Analysis (PLS-DA)
18%
Female Participants
18%
Traditional Japanese Medicine
9%
Molecular Mechanism
9%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
9%
Gas Chromatography-mass Spectrometry
9%
Amino Acids
9%
Univariate Analysis
9%
Cognitive Impairment
9%
Nervous System
9%
Blood Samples
9%
Dementia
9%
MS-MS
9%
Metabolite Concentrations
9%
Kampo
9%
Pathophysiological Roles
9%
Female Patients
9%
Progressive Neurodegeneration
9%
Adjuvant Effect
9%
Physiological Role
9%
Plasma Samples
9%
Major Contributor
9%
Multicenter Trial
9%
Drug Administration
9%
Disease-based
9%
Functional Metabolomics
9%
MS Method
9%
Web-based Software
9%
MetaboAnalyst
9%
Change Dynamics
9%
Variable Importance in Projection
9%
Neuroscience
Alzheimer's Disease
100%
Hachimijiogan
100%
Blood Plasma
100%
Cognitive Disorders
27%
Acetylcholine
27%
Aspartic Acid
18%
Nervous System
9%
Amino Acid
9%
Neurodegeneration
9%
Kampo Medicine (Drug)
9%
Liquid Chromatography-Mass Spectrometry
9%
Adjuvant Therapy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Hachimijiogan
100%
Acetylcholine
27%
Cognitive Defect
27%
Aspartic Acid
18%
Kampo Medicine (Drug)
9%
Disease
9%
Amino Acid
9%
Nerve Degeneration
9%
Deterioration
9%
Drug Administration
9%